• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

烟曲霉的生物膜形成。

Biofilm formation by Aspergillus fumigatus.

机构信息

School of Biotechnology, Gautam Buddha University, Greater Noida, India.

出版信息

Med Mycol. 2014 Jan;52(1):2-9. doi: 10.3109/13693786.2013.819592.

DOI:10.3109/13693786.2013.819592
PMID:23962172
Abstract

Aspergillus fumigatus is a well adapted, opportunistic fungus that causes a severe and commonly fatal disease, invasive pulmonary aspergillosis (IPA), in highly immunocompromised patients, aspergilloma in patients with lung cavities and allergic bronchopulmonary aspergillosis (ABPA) in hypersensitive individuals. Recent studies have suggested that biofilm formation by A. fumigatus may be one of the most important virulence factors in IPA and aspergilloma. Several fungal constituents may contribute to the formation of biofilm structures on host cells, including cell wall components, secondary metabolites and drug transporters. The biofilm phenotype of the fungus is refractory to most conventional antifungal treatment options. Thus, an in-depth analysis and understanding of A. fumigatus biofilms is necessary to devise newer and better antifungal targets for treating complex A. fumigatus biofilm-associated diseases.

摘要

烟曲霉是一种适应性强的机会致病菌,可导致严重且通常致命的疾病,包括免疫功能低下患者的侵袭性肺曲霉病(IPA)、肺空洞患者的曲霉肿和过敏个体的变应性支气管肺曲霉病(ABPA)。最近的研究表明,烟曲霉的生物膜形成可能是 IPA 和曲霉肿最重要的毒力因素之一。一些真菌成分可能有助于在宿主细胞上形成生物膜结构,包括细胞壁成分、次级代谢产物和药物转运蛋白。真菌的生物膜表型对大多数常规抗真菌治疗方法具有耐药性。因此,深入分析和了解烟曲霉生物膜对于设计新型更好的抗真菌靶点以治疗复杂的烟曲霉生物膜相关疾病是必要的。

相似文献

1
Biofilm formation by Aspergillus fumigatus.烟曲霉的生物膜形成。
Med Mycol. 2014 Jan;52(1):2-9. doi: 10.3109/13693786.2013.819592.
2
Aspergillus fumigatus biofilms: Toward understanding how growth as a multicellular network increases antifungal resistance and disease progression.烟曲霉生物膜:深入了解作为一个多细胞网络的生长如何增加抗真菌药物耐药性和疾病进展。
PLoS Pathog. 2021 Aug 26;17(8):e1009794. doi: 10.1371/journal.ppat.1009794. eCollection 2021 Aug.
3
Exploring the intersection of Aspergillus fumigatus biofilms, infections, immune response and antifungal resistance.探索烟曲霉生物膜、感染、免疫反应和抗真菌耐药性的交集。
Mycoses. 2023 Sep;66(9):737-754. doi: 10.1111/myc.13619. Epub 2023 May 22.
4
Aspergillus fumigatus biofilms in the clinical setting.临床环境中的烟曲霉生物膜。
Med Mycol. 2011 Apr;49 Suppl 1:S96-S100. doi: 10.3109/13693786.2010.502190. Epub 2011 Jan 24.
5
An Alanine Aminotransferase Is Required for Biofilm-Specific Resistance of Aspergillus fumigatus to Echinocandin Treatment.丙氨酸氨基转移酶对于烟曲霉生物膜对抗真菌药物棘白菌素治疗的抗性是必需的。
mBio. 2022 Apr 26;13(2):e0293321. doi: 10.1128/mbio.02933-21. Epub 2022 Mar 7.
6
The Gene Is Required for the Growth and Virulence of the Human Pathogenic Fungus Aspergillus fumigatus.该基因是人类致病真菌烟曲霉生长和毒力所必需的。
Microbiol Spectr. 2022 Feb 23;10(1):e0155821. doi: 10.1128/spectrum.01558-21. Epub 2022 Feb 2.
7
Aspergillus Biofilm In Vitro and In Vivo.曲霉生物膜的体外与体内研究。
Microbiol Spectr. 2015 Aug;3(4). doi: 10.1128/microbiolspec.MB-0017-2015.
8
Aspergillus fumigatus metabolism: clues to mechanisms of in vivo fungal growth and virulence.烟曲霉代谢:体内真菌生长和毒力机制的线索
Med Mycol. 2009;47 Suppl 1(Suppl 1):S72-9. doi: 10.1080/13693780802455313. Epub 2009 Feb 27.
9
Preclinical Evaluation of Recombinant Microbial Glycoside Hydrolases in the Prevention of Experimental Invasive Aspergillosis.重组微生物糖苷水解酶在预防实验性侵袭性曲霉病中的临床前评价。
mBio. 2021 Oct 26;12(5):e0244621. doi: 10.1128/mBio.02446-21. Epub 2021 Sep 28.
10
Aspergillus fumigatus forms biofilms with reduced antifungal drug susceptibility on bronchial epithelial cells.烟曲霉在支气管上皮细胞上形成生物膜,对抗真菌药物的敏感性降低。
Antimicrob Agents Chemother. 2008 Nov;52(11):4130-6. doi: 10.1128/AAC.00234-08. Epub 2008 Aug 18.

引用本文的文献

1
Comprehensive Review of Environmental Surveillance for Azole-Resistant : A Practical Roadmap for Hospital Clinicians and Infection Control Teams.唑类耐药环境监测综合综述:医院临床医生和感染控制团队实用路线图
J Fungi (Basel). 2025 Jan 25;11(2):96. doi: 10.3390/jof11020096.
2
Current Updates on Pathogenesis, Systemic Therapy, and Treatment of Invasive Fungal Infections.侵袭性真菌感染的发病机制、全身治疗及治疗的最新进展
Curr Drug Targets. 2025;26(3):203-220. doi: 10.2174/0113894501337502241015121015.
3
CRISPR/Cas9 mediated targeted knock-in of eglA gene to improve endoglucanase activity of Aspergillus fumigatus LMB-35Aa.
CRISPR/Cas9 介导的靶向敲入 eglA 基因以提高烟曲霉 LMB-35Aa 的内切葡聚糖酶活性。
Sci Rep. 2024 Aug 23;14(1):19661. doi: 10.1038/s41598-024-70397-4.
4
Protein disulfide isomerase 1 is required for RodA assembling-based conidial hydrophobicity of .蛋白二硫键异构酶 1 是基于 RodA 组装的分生孢子疏水性所必需的。
Appl Environ Microbiol. 2024 Apr 17;90(4):e0126023. doi: 10.1128/aem.01260-23. Epub 2024 Mar 19.
5
Effect of 5-Aminolevulinic Acid Photodynamic Therapy on Aspergillus fumigatus Biofilms in Vitro.5-氨基酮戊酸光动力疗法对体外烟曲霉生物膜的影响。
Curr Microbiol. 2023 Sep 2;80(10):334. doi: 10.1007/s00284-023-03351-8.
6
Infection, Allergy, and Inflammation: The Role of in Cystic Fibrosis.感染、过敏与炎症:[具体物质或因素]在囊性纤维化中的作用 。(原文中“in”后面的内容缺失)
Microorganisms. 2023 Aug 5;11(8):2013. doi: 10.3390/microorganisms11082013.
7
Breakthrough Invasive Sinusitis by Hormographiella aspergillata in a Neutropenic Patient Receiving Voriconazole Therapy: A Case Report and Review of Breakthrough H. aspergillata Infections.中性粒细胞减少症患者接受伏立康唑治疗时被aspergillata 型霍氏曲霉引起的侵袭性鼻窦突破:病例报告和对霍氏曲霉突破感染的回顾。
Mycopathologia. 2023 Aug;188(4):401-407. doi: 10.1007/s11046-023-00768-4. Epub 2023 Jun 30.
8
Survival Factor A (SvfA) Contributes to Pathogenicity.生存因子A(SvfA)有助于致病性。
J Fungi (Basel). 2023 Jan 21;9(2):143. doi: 10.3390/jof9020143.
9
Immunopathologic Role of Fungi in Chronic Rhinosinusitis.真菌在慢性鼻-鼻窦炎中的免疫病理作用。
Int J Mol Sci. 2023 Jan 25;24(3):2366. doi: 10.3390/ijms24032366.
10
Lipid-Like Biofilm from a Clinical Brain Isolate of Aspergillus terreus: Quantification, Structural Characterization and Stages of the Formation Cycle.来自土曲霉临床分离株的类脂生物膜:定量、结构特征和形成周期阶段。
Mycopathologia. 2023 Apr;188(1-2):35-49. doi: 10.1007/s11046-022-00692-z. Epub 2022 Dec 14.